Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Alzheimer's / February 2006

Tip: Looking for answers? Try searching our database.

Statin disabling Adverse Effects put patient AND spouse at risk

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
Sharon Hope - 17 Feb 2006 04:51 GMT
An important new study done by the Harvard Medical School and published in
the New England Journal of medicine has identified and quantified some risk
to caregivers.

The news report about the study did not mention statins directly, but we all
bring information we already know to what we read.

In my case, I know Lipitor 10 mg/day for 4 years can, and did, cause severe
disability in my spouse of over 35 years - chronic extreme pain, muscle
deterioration, elevated CK (putting kidneys and liver at risk),
mitochondrial damage, myopathy, myositis, peripheral neuropathy, insomnia,
transient global amnesia, severe cognitive damage, aphasia, and extreme
short-term memory loss (DEMENTIA is another term for such memory loss), and
now exertion-induced gout - this in a high-achieving, vigorous, very
successful man in his early 50s, twice a corporate CEO.

The severe disability destroyed his health, cognitive abilities, ability to
funciton, ability to stand, ability to walk or interact with people - and
needless to say destroyed his business and quality of life.

Four years off the Lipitor, there has been some recovery - enough certainly
to absolutely point to the Lipitor as the cause - but not yet enough to go
beyond a seriously disabled state.

Rather than allow myself to sink into a bottomless pit of despair, I, like
so many spouses of similarly disabled statin patients I have since had the
honor to know (however unfortunate our shared pain), have devoted nearly
every waking minute to being a champion for my spouse, seeking out the best
doctors, searching for a treatment toward a cure, and collecting
peer-reviewed medical journal publications that are evidence of such
disabling statin adverse effects - in hopes of warning others and preventing
them from going through what we have experienced. (That, and working 50 to
60 hour weeks at a demanding job to maintain an income.)  Other spouses and
family members of statin-disabled have made similar contributions,
establishing and maintaining a message board for others, for example.

My husband bravely allowed a fine journalist, Eleanor Laise of Smart Money
Magazine, to publicize and expose his own drastically disabled state in a
national magazine, in hopes someone might benefit from his pain and
debilitation. We know it helped many more than the scores of people who
contacted us personally to thank us for helping them to understand the
problems they, too, were experiencing on statins.

Many have quietly thanked us for sounding the alarm.  Some moronic trolls
have attempted to discredit the effort - objecting blythely to one or two of
hundreds of published studies - as if that objection is of higher quality
than the journal that published the article and as if the other hundreds of
references did not exist - or attacking the effort by ascribing dark
motives, or insisting it was motivated by guilt in a very sick
blame-the-patient-and-shoot-the-messenger perverted way of thinking and
acting, or even claiming the pain and suffering is irrelevant because it is
not universal or 'rare', or irrationally claiming it was somehow fortunate
because it was the only possible alternative to a guaranteed certain heart
attack (no mention of how the human race has lasted this long, given this
line of thinking that leads these ng lurkers to insist the only choices in
life are to take a statin or die of a heart attack).  (Odd, too, that faced
with such extreme adversity on a daily basis as we spouses/families of the
statin-disabled are, these nay-saying ng trolls actually seem to think their
negativity could make any impression at all.)

I don't think it ever occurred to us spouses that we were fighting for more
than just the health of our spouses, the good of our families, and the
chance some unknown families need not be similarly damaged.  We knew, of
course, the impact to our and our family's quality of life, the drastic
financial damage that occurred in what would have been peak earning years -
while putting the kids through college, and the heartache of seeing a
beloved spouse in a blind tunnel of horrific pain 24-hours a day with
absolutely no respite.

It turns out, at least according to the results of the aforementioned study,
we were also fighting for our own very lives!

According to the study, we female spouses of statin-caused Dementia patients
are at
an AVERAGE of TWENTY EIGHT PERCENT higher risk of death.  This is higher
than the 17% increased risk of our death upon the death of a spouse.
Caregivers of dementia patients are themselves at higher risk of dying!

For those who might be in a similar caregiver position of a dementia patient
or otherwise disabled spouse, regardless of cause, this study is something
you should know about.  I don't have the full-text version, and because of
copyright rules, I will not post the entire article, only those points that
I found worthy of highlight, but you owe it to yourselves to read the full
article - and send it on to others who should know about it.

http://www.foxnews.com/story/0,2933,185104,00.html

Caretakers of Ill Spouses Have Greater Risk of Death

Thursday, February 16, 2006

By Daniel J. DeNoon

Seniors who care for their seriously ill spouses may pay the ultimate price.

A groundbreaking new study shows that caring for a sick spouse can raise the
caretaker's risk of death. For some particularly disabling illnesses --
dementia, in particular -- the toll on the caretaker is worse than the toll
of a spouse's death.

It's been known for more than 150 years that the death of a spouse ups the
surviving partner's risk of death. Now it's shown that illness, too, can
break your heart.

"We showed you can die of a broken heart not just when your partner dies,
but when your partner falls ill," researcher Nicholas Christakis, MD, PhD,
said in a news conference. "We showed it is not just death that can give you
a broken heart, but illness -- even when the spouses don't die."

Christakis, professor health care policy at Harvard Medical School in
Boston, and colleagues report the findings in the Feb. 16 issue of The New
England Journal of Medicine.

<read more at the link provided>

The death of a spouse increased a man's risk of death by 21 percent and a
woman's risk of death by 17 percent. Overall, the illness of a spouse was
only one-fifth as deadly to caretakers as the death of a spouse.

But some spousal illnesses took at least as great a toll as death:

--A spouse's psychiatric illness raised the risk of death by 19 percent for
men and by 32 percent for women.

--A spouse's dementia raised the risk of death by 22 percent for men and by
28 percent for women.

--Other diseases that take a heavy toll on caretakers included heart
failure, hip fracture or other serious fracture, and chronic lung disease.

--A spouse's cancer did not increase caretaker death risk.

"It is the disablement and not the lethality of a spouse's illness that can
be harmful to you and contribute to your risk of dying," Christakis says.

There's another factor that makes it hard on spouses: poverty.

<read more at the link provided>

"Because people are interconnected, we think this phenomenon we studied in
elderly married couples applies more generally," Christakis says. "We are
looking at broader connections -- between parent and child, brother and
sister, neighbors, and friends."

By Daniel J. DeNoon, reviewed by Louise Chang, MD

SOURCES: Christakis, N.A. The New England Journal of Medicine, Feb. 16,
2006; vol 354: pp 719-730. Nicholas Christakis, MD, PhD, professor,
department of health care policy, Harvard Medical School, Boston. Suzanne
Salamon, MD, associate chief, clinical geriatrics, Beth Israel Deaconess
Medical Center, Boston.
Tumbleweed - 17 Feb 2006 09:11 GMT
[crossposting removed]

> An important new study done by the Harvard Medical School and published in
> the New England Journal of medicine has identified and quantified some
[quoted text clipped - 4 lines]
> all
> bring information we already know to what we read.

Thats because its nothing to do with statins,or any disease per se,  its to
do with the stress brought about by caring for a severly ill relative.

> In my case, I know Lipitor 10 mg/day for 4 years can, and did, cause
> severe
[quoted text clipped - 5 lines]
> and now exertion-induced gout - this in a high-achieving, vigorous, very
> successful man in his early 50s, twice a corporate CEO.

The latter bit is irrelevant, so what if he was a CEO or 'high achieving',
would it have been OK if he was a janitor or a plumber?
The earlier and more relevant question is...why wasnt someone; doctor,
consultant, the person themselves, their partner, monitoring for side
effects when he started on the drug?

>(no mention of how the human race has lasted this long, given this
> line of thinking that leads these ng lurkers to insist the only choices in
> life are to take a statin or die of a heart attack).

You need to understand the difference between 'the human race' and a single
human life. For most of time, the vast majority of people would have been
dead by 30 or 40, and women not reproducing over 30, so nature doesnt "care"
what happens to you after that.

> It turns out, at least according to the results of the aforementioned
> study,
[quoted text clipped - 5 lines]
> than the 17% increased risk of our death upon the death of a spouse.
> Caregivers of dementia patients are themselves at higher risk of dying!

Thats hardly news to most of us in the Az group. It would probably be higher
if it was just Az.

Signature

Tumbleweed

email replies not necessary but to contact use;
tumbleweednews at hotmail dot com

Sharon Hope - 18 Feb 2006 02:06 GMT
> [crossposting removed]

>> According to the study, we female spouses of statin-caused Dementia
>> patients are at
[quoted text clipped - 4 lines]
> Thats hardly news to most of us in the Az group. It would probably be
> higher if it was just Az.

The 28% increased risk of death is for caregivers of spouses having
dementia.  Dementia is dementia, regardless of cause.  It is very difficult
to tell the difference between statin-caused dementia and Alzheimer's by the
net effects on the patient.

However, the toll from statins SHOULD be preventable, even though
Alzheimer's is not yet.

Unfortunately, many prescribing doctors do not monitor for memory loss due
to statins, probably because they have been subjected to so much spin on how
statins 'might' prevent Alz, despite all the studies finding it does not.
And despite the fact that not one study is set up to include a way to
discriminate between statin-caused memory loss and Alzheimer's - making each
dreadfully flawed.

The fact that both Australia and Canada now warn about statins causing
cognitive damage and memory loss has not influenced the FDA to warn about
it, so not many more doctors monitor for it today than did 8 years ago when
it would have done my husband some good.

So yes, perhaps the outrage we spouses of statin dementia patients feel
about the failure of the doctor to monitor for the known side effects of the
drug he himself prescribed helps us rally a bit better than Alzheimer's
spouses.  But dementia is dementia nonetheless.

Then, again, there is the too horrific to even contemplate possibility of an
ignorant doctor prescribing statins for an Alzheimer's patient, and causing
even more cognitive damage, dementia, amnesia, aphasia and neurological
damage than the Alz would have caused without the statin adverse effects.
It gives one a chill to think that this 'Alz market' is being exploited by
the makers of this class of drugs.
Tumbleweed - 18 Feb 2006 08:43 GMT
> Then, again, there is the too horrific to even contemplate possibility of
> an ignorant doctor prescribing statins for an Alzheimer's patient, and
> causing even more cognitive damage, dementia, amnesia, aphasia and
> neurological damage than the Alz would have caused without the statin
> adverse effects. It gives one a chill to think that this 'Alz market' is
> being exploited by the makers of this class of drugs.

I think its unlikely that would happen, given that statins are generally
prescribed for long term use, not much point staving off a heart attack in
say 10-15 years time for someone whose life expectancy is 5-10 years
Signature

Tumbleweed

email replies not necessary but to contact use;
tumbleweednews at hotmail dot com

Anthony Shipley - 18 Feb 2006 10:49 GMT
>> Then, again, there is the too horrific to even contemplate possibility of
>> an ignorant doctor prescribing statins for an Alzheimer's patient, and
[quoted text clipped - 6 lines]
>prescribed for long term use, not much point staving off a heart attack in
>say 10-15 years time for someone whose life expectancy is 5-10 years

Well,  I've been on statins since for some years longer than the AD stuff.

anthony shipley

Run away with me; I can make you unhappy.
Sharon Hope - 18 Feb 2006 20:22 GMT
>>> Then, again, there is the too horrific to even contemplate possibility
>>> of
[quoted text clipped - 11 lines]
>
> anthony shipley

Anthony,

Have your doctors specifically eliminated the statins as the cause of your
memory loss?  If not, it should definitely be done.

More info on this is available at the following sites:

The NIH-funded University of California, San Diego, Statin Study:
http://medicine.ucsd.edu/ses/
See expecially:
http://medicine.ucsd.edu/ses/adverse_effects.htm#Lesser%20known%20side%20effects
This study is led by Dr. Beatrice Golomb, the foremost expert on statin
cognitive damage and memory loss.

Dr. Graveline's website:
http://www.spacedoc.net/
Dr. Graveline is an MD who suffered statin amnesia.  He was a NASA Science
Astronaut, a US Air Force Flight Surgeon, and a family doctor.  He has
written 2 books on statin cognitive damage and memory loss.

Dr. Cohen's book WHAT YOU MUST KNOW ABOUT STATIN DRUGS AND THEIR NATURAL
ALTERNATIVES
also has some useful information on these adverse effects.

> Run away with me; I can make you unhappy.
Anthony Shipley - 19 Feb 2006 09:29 GMT
>Anthony,
>
>Have your doctors specifically eliminated the statins as the cause of your
>memory loss?  If not, it should definitely be done.

I hope I never gave that impression. The statins have always been for
cholesterol. The memory loss has been diagnosed as A.D and it treated by
Reminyl.

anthony shipley

Run away with me; I can make you unhappy.
Sharon Hope - 19 Feb 2006 18:19 GMT
Just so you know, the statin memory loss starts very slowly - detectable by
specialized testing at 6 months, but it can be years before you or your
family would notice the problem.

Because of the lag, many people who have statin memory loss don't connect it
to the statin drug.  They think that because they have taken it for years
and it wasn't "new" at the time the memory loss symptoms started it must not
be connected.  When, in fact, it is the cause.

Not saying your diagnosis is wrong, but if your doctors haven't explicitly
looked for a statin connection and eliminated the possibility, they should.

Just for general information, according to a presentation by Dr. Golomb, the
principal investigator in the NIH-funded UCSD Statin Study
(http://medicine.ucsd.edu/ses/), for those who lost memory or cognitive
ability on statins, by halting statins they were able to recover up to 80%
of their previous abilities.  If they take a different statin after this
recovery, the likelihood is extremely high that they will experience the
same cognitive and memory symptoms.  If that happens, and they halt the
statin, the most they can expect is 80% of this statin's pre-statin
abilities - those were already down by 80% because of the first statin.  So,
after the second statin, the best the patient can recover is 64% of their
normal abilities.

>>Anthony,
>>
[quoted text clipped - 8 lines]
>
> Run away with me; I can make you unhappy.
Tumbleweed - 19 Feb 2006 09:03 GMT
>>> Then, again, there is the too horrific to even contemplate possibility
>>> of
[quoted text clipped - 9 lines]
>
> Well,  I've been on statins since for some years longer than the AD stuff.

I was talking about the other way round anthony, eg Az first, then being
prescribed statins. Might be worth you discontinuing the statins for a few
months and see what happens, maybe you are in the small minority
(anecdotally reported) that have memory problems. Its not as if it would be
life-threatening to stop them, unless you have *very* high Choleresterol.

Signature

Tumbleweed

email replies not necessary but to contact use;
tumbleweednews at hotmail dot com

Anthony Shipley - 19 Feb 2006 09:32 GMT
>I was talking about the other way round anthony, eg Az first, then being
>prescribed statins. Might be worth you discontinuing the statins for a few
>months and see what happens, maybe you are in the small minority
>(anecdotally reported) that have memory problems. Its not as if it would be
>life-threatening to stop them, unless you have *very* high Choleresterol.

I'm not a doctor etc so I don't choose to guess of what my doctor(s) prescribe.
That's just stupidity.

anthony shipley

Run away with me; I can make you unhappy.
Tumbleweed - 19 Feb 2006 17:19 GMT
>>I was talking about the other way round anthony, eg Az first, then being
>>prescribed statins. Might be worth you discontinuing the statins for a few
[quoted text clipped - 6 lines]
> prescribe.
> That's just stupidity.

You could ask. If you really have been diagnosed with Az (which is different
from having Az), and if the statins came before the memory problems and the
diagnosis, and since memory loss is a side effect of statins(even if only in
a v small number of people) and since statins are for long term heart
problems which no one with Az is likely to live long enough to see
.....well, draw your own conclusions.

Signature

Tumbleweed

email replies not necessary but to contact use;
tumbleweednews at hotmail dot com

carolinasongbird@gmail.com - 19 Feb 2006 17:39 GMT
Anthony,

I agree with Tumbleweed on this one. Not all docs are aware of the
statin-memory loss connection, and many think statins are as innocuous
as Tylenol. (and yet I have a family member who had Tylenol-induced
hepatitis AND I am a fan of statins -- my mom and my husband are both
on them.) It wouldn't hurt just to ask if there's a possibility the
statins might be contributing to your problem.

To be honest, Anthony, you are an atypical Alz patient -- my mom, who
still has an MMSE of 27, can't even sign onto the computer, much less
carry on the lively conversations you do. I'm not saying you DON'T have
Alz -- I'm not a doctor. But I would hate to think there was a
reversible condition masquerading as something more deadly, and I could
not in good conscience consider myself your friend if I didn't
encourage you to check it out.

Songbird
Dennis P. Harris - 19 Feb 2006 21:29 GMT
> To be honest, Anthony, you are an atypical Alz patient -- my mom, who
> still has an MMSE of 27, can't even sign onto the computer, much less
[quoted text clipped - 3 lines]
> not in good conscience consider myself your friend if I didn't
> encourage you to check it out.

From what he has posted on this group, Anthony is not interested
in what others who might have more insight into his condition
might think, because he apparently knows better than anybody else
all about his condition, even though he accepts what his doctor
prescribes and would never question it:

> I'm not a doctor etc so I don't choose to guess of what my doctor(s)
> prescribe.  That's just stupidity.

I think that he's just an ignorant troll, which is while he's in
my killfile.  But you're right, if he's taking statins, that's
certainly a possible explanation for his condition even if he
wants to remain blissfully ignorant.
Anthony Shipley - 20 Feb 2006 00:39 GMT
>From what he has posted on this group, Anthony is not interested
>in what others who might have more insight into his condition
>might think, because he apparently knows better than anybody else
>all about his condition, even though he accepts what his doctor
>prescribes and would never question it:
Nothing like a poster spurned.

Thanks, Dennis, you are welcome to treat me as a troll.

>> I'm not a doctor etc so I don't choose to guess of what my doctor(s)
>> prescribe.  That's just stupidity.
[quoted text clipped - 3 lines]
>certainly a possible explanation for his condition even if he
>wants to remain blissfully ignorant.

anthony shipley

Run away with me; I can make you unhappy.
Anthony Shipley - 20 Feb 2006 00:34 GMT
>Anthony,
>
[quoted text clipped - 4 lines]
>on them.) It wouldn't hurt just to ask if there's a possibility the
>statins might be contributing to your problem.
I'm certainly going to follow my doctor's  prescriptions rather than some
nameless face. Cite, by all means, respectable research; refer to creditable
research and cite the papers.

>To be honest, Anthony, you are an atypical Alz patient -- my mom, who
>still has an MMSE of 27, can't even sign onto the computer, much less
>carry on the lively conversations you do. I'm not saying you DON'T have
>Alz -- I'm not a doctor.

>But I would hate to think there was a
>reversible condition masquerading as something more deadly, and I could
>not in good conscience consider myself your friend if I didn't
>encourage you to check it out.
You never mentioned you were a research scientist.....

anthony shipley

Run away with me; I can make you unhappy.
Sharon Hope - 20 Feb 2006 17:30 GMT
> I'm certainly going to follow my doctor's  prescriptions rather than some
> nameless face. Cite, by all means, respectable research; refer to
> creditable
> research and cite the papers.

Anthony,

That is precisely the correct response.  Below find the published
peer-reviewed medical journal articles & study abstracts that you can take
to your doctor.  At the end, a letter that requests that the doctor, if
statin memory loss is at fault, report the adverse effects.

Just before that, however, an excerpt from a recent People's Pharmacy column
specific to statin memory loss mis-diagnosed as Alzheimer's:

Excerpt from People's Pharmacy:
http://www.peoplespharmacy.org/archives/editorial/are_cholesterol_drugs_linked_t
o_memory_loss.asp


"Recently we heard of another disturbing experience. Michael Kirk-Duggan was
a retired professor of business law and computer science. He was diagnosed
with probable Alzheimer's disease that was progressing very rapidly. He went
to his 50th college reunion with a sign around his neck that said, "I'm
Mike. I have Alzheimer's disease." At his youngest daughter's wedding, he
did not recognize people he had known more than 20 years.
His decline made it clear that he would need long-term nursing care. But
then he read our column about statins and memory problems. With his doctor's
awareness, he discontinued the Zocor he had been taking. Although it took
many months, he gradually regained his memory and cognitive ability. He is
back to reading three newspapers a day and is sharp as a tack. A complete
neurological workup showed no signs of Alzheimer's disease."

AMNESIA, MEMORY LOSS & STATINS

Lipitor, Thief of Memory, by Duane Graveline M.D.
Dr. Graveline, retired family MD, USAF Flight Surgeon, researcher in space
medicine and US Astronaut, who suffered adverse effects from Lipitor,
maintains several websites and is working on a second book about statin
adverse effects, including statin-related memory loss and amnesia at:

www.spacedoc.net (you can start here and read about his life and his books)

http://www.spacedoc.net/lipitor_thief_of_memory.html

http://www.spacedoc.net/lipitor.htm

http://www.spacedoc.net/statin_dialogues.htm

Australian Adverse Drug Reactions Bulletin (Australia's equivalent to the
FDA)

Volume 17, Number 3, August 1998, section 3, page 3

Simvastatn is listed under "DRUGS THAT MAKE YOU FORGET"

Recognizing the 14 reports of Amnesia under that drug, .8% of the total
adverse effects for that drug.

www.health.gov.au/tga/docs/pdf/aadrbltn/aadr9808.pdf

Am J Med. 2004 Dec 1;117(11):823-9.

Randomized trial of the effects of simvastatin on cognitive functioning in
hypercholesterolemic adults.

Muldoon MF, Ryan CM, Sereika SM, Flory JD, Manuck SB.

Center for Clinical Pharmacology, University of Pittsburgh, Pennsylvania
15260, USA. mfm10@pitt.edu

"This study provides partial support for minor decrements in cognitive
functioning with statins. Whether such effects have any long-term sequelae
or occur with other cholesterol-lowering interventions is not known." This
is the second of two studies by Muldoon, both showing measurable cognitive
decline in statin groups after only 6 months, using Neuropsych testing.
Further, the cognitive deficits appear consistently in specific areas.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstra
ct&list_uids=15589485


Golomb BA, Yang E, Denenberg J, Criqui M (2003),

Statin-associated adverse events. P95. Presented at the 43rd Annual
Conference on Cardiovascular Disease Epidemiology and Prevention. Miami;
March 5-8.

Muldoon MF, Ryan CM, Flory JD, Manuck SB (2002),

Effects of simvastatin on cognitive functioning.

Presented at the American Heart Association Scientific

Sessions. Chicago; Nov. 17-20.

Muldoon MF, Barger SD, Ryan CM, Flory JD, Lehoczky JP, Matthews KA, Manuck
SB.

Effects of lovastatin on cognitive function and psychological well-being.

After 6 months, 100% of the patients on placeboes showed a measurable
increase in cognitive function, and 100% of the statin patients showed a
measurable decrease in cognitive function.

Am J Med. 2000 May;108(7):538-46.

PMID: 10806282 [PubMed - indexed for MEDLINE]

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1
0806282&dopt=Abstract


Cognitive impairment associated with atorvastatin and simvastatin.

King DS, Wilburn AJ, Wofford MR, Harrell TK, Lindley BJ, Jones DW.

Department of Medicine, University of Mississippi Medical Center, Jackson,
Mississippi 39216, USA. dking@pharmacy.umsmed.edu

Pharmacotherapy. 2003 Dec;23(12):1663-7.

"we report two women who experienced significant cognitive impairment
temporally related to statin therapy. One woman took atorvastatin, and the
other first took atorvastatin, then was rechallenged with simvastatin.
Clinicians should be aware of cognitive impairment and dementia as potential
adverse effects associated with statin therapy."  PMID: 14695047

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstra
ct&list_uids=14695047


Cognitive impairment associated with atorvastatin.

King DS, Jones DW, Wofford MR et al. (2001), Presented at the American
College of Clinical Pharmacy Spring Practice and Research Forum. Salt Lake
City; April 22-25.

Australian Adverse Drug Reactions Bulletin (Australia's equivalent to the
FDA)

Volume 17, Number 3, August 1998, section 3, page 3

Simvastatn is listed under "DRUGS THAT MAKE YOU FORGET"

Recognizing the 14 reports of Amnesia under that drug, .8% of the total
adverse effects for that drug.

www.health.gov.au/tga/docs/pdf/aadrbltn/aadr9808.pdf

Statin-associated memory loss: analysis of 60 case reports and review of the
literature.

Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM.

Drug Information Service, Duke University Medical Center, Durham, North
Carolina 27710, USA.  Pharmacotherapy. 2003 Jul;23(7):871-80.

This study searched the MedWatch drug surveillance system of the Food and
Drug Administration (FDA) from November 1997-February 2002 for reports of
statin-associated memory loss. They also reviewed the published literature.
References from the study are good for follow-up research.

Abstract:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1
2885101&dopt=Abstract


Full Study Text free on Medscape:

http://www.medscape.com/viewarticle/458867

The Role of Lipid-Lowering Drugs in Cognitive Function: A Meta-Analysis of
Observational Studies

from Pharmacotherapy

Posted 06/30/2003

Mahyar Etminan, Pharm.D., Sudeep Gill, M.D., FRCPC, Ali Samii, M.D., FRCPC

Although this study does bring the cognitive issues to light, it is a very
poor study.  The authors left out the pivotal study by Dr. Muldoon, that
showed nearly 100% of statin users had a  measurable loss of cognitive
ability after 6 months, while 100% of the placebo group improved their
scores.

Abstract:

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1
2820814&dopt=Abstract


Full Study Text free on Medscape:

http://www.medscape.com/viewarticle/456866

Simvastatin-Associated Memory Loss

Amanda Orsi, Pharm.D., Olga Sherman, Pharm.D., and Zegga Woldeselassie,
Pharm.D.,

Abstract: The statins are widely used to treat dyslipidemias. They are
generally associated with mild adverse effects, but rarely, more serious
reactions may occur. A 51-year-old man experienced delayed-onset,
progressive memory loss while receiving simvastatin for
hypercholesterolemia. His therapy was switched to pravastatin, and memory
loss resolved gradually over the next month, with no recurrence of the
adverse effect.

from Pharmacotherapy

Posted 06/01/2001

Page 1 of 3:
http://www.medscape.com/viewarticle/409738?WebLogicSession=PXke2H8h99pyNVSCajAh5
clptzOAHJSZuNBobSwWmi9veWjdJ2A3%7C-1468812056489609316/184161392/6/7001/7001/700
2/7002/7001/-1


full printable version: http://www.medscape.com/viewarticle/409738_print

ADR of the Month

September 2001 Vol. 6 No. 9

EDITORS

Michelle W. McCarthy, Pharm.D.

Anne E. Hendrick, Pharm.D.

University of Virginia Health System

Department of Pharmacy Services

Drug Information Center

PO Box 800674

Charlottesville, VA 22908-0674

http://hsc.virginia.edu/pharmacy-services/Newsletters/ADR%20of%20the%20Month/ADR
Month%209-01htm.html


The Tablet, a general member benefit published by the British Columbia
Pharmacy Association, September 2001, Volume 10 no 8.

Excerpt:

Do HMG-CoA reductase inhibitors impair memory? After taking simvastatin for
a year, a 51-year-old patient developed short term memory loss, to the
extent of being unable to complete his sentences because he would forget
what he was going to say. The drug was discontinued, replaced by
pravastatin, and within one month his memory returned.14 In a separate case,
a 67-year-old woman developed impaired short-term memory, altered mood,
social impairment, cognitive impairment and dementia after one year of
atorvastatin therapy. When atorvastatin was discontinued, her memory, mood
and cognition improved completely.15 Memory impairment in a patient
receiving atorvastatin has been reported to the BC Regional ADR Centre.

REFERENCES:

14. Orsi A, Sherman O, Woldeselassie Z. Simvastatin-associated memory loss.

15. King DS, Jones DW, Wofford MR et al. First report of cognitive
impairment in an elderly patient: case report. Pharmacotherapy 2001 Mar; 21:
371.

http://www.bcpharmacy.ca/publications/thetablet/pdf_version/BCPhA_Tablet-Sep2001.pdf

See page 11 of 16:

See also:

Statins and risk of polyneuropathy, A case-control study

D. Gaist, MD, PhD; U. Jeppesen, MD, PhD; M. Andersen, MD, PhD; L.A. García
Rodríguez, MD, MSc;

J. Hallas, MD, PhD; and S.H. Sindrup, MD, PhD

http://213.4.18.135/87.pdf full text

Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase
inhibitor.

von Keutz E, Schluter G.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9
737641&dopt=Abstract


Institute of Toxicology, PH-Product Development, Bayer AG, Wuppertal,
Germany

Am J Cardiol. 1998 Aug 27;82(4B):11J-17J.

PMID: 9737641

"In dogs, the species most sensitive to statins, cerivastatin caused
erosions and hemorrhages in the gastrointestinal tract, bleeding in the
brain stem with fibroid degeneration of vessel walls in the choroid plexus,
and lens opacity."

Subchronic toxicity of atorvastatin, a hydroxymethylglutaryl-coenzyme A
reductase inhibitor, in beagle dogs.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8
864188&dopt=Abstract


Walsh KM, Albassam MA, Clarke DE.

Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann
Arbor, Michigan 48105, USA.

"The toxicity of atorvastatin (AT), an inhibitor of
hydroxymethylglutaryl-coenzyme A reductase (HMG), was evaluated in beagle
dogs. hemorrhage in gallbladder and brain, demyelination of optic nerve, and
skeletal muscle necrosis"

Finally, on memory loss and statins: Sworn testimony from the Baycol trial
in Corpus Christi, Texas. From the transcript of the AM Session on 03-05-03,
in the case Hollis Haltom Vs. Bayer Corporation. Testifying under oath,., in
response to the plaintiff's attorney's question, "What is your current
position at Bayer?", LAWRENCE POSNER, M.D of BAYER stated: "I'm the --  
currently I'm the head of worldwide regulatory affairs for our prescription
drug business, which means I have responsibility in somewhere between 60 and
100 countries where we sell products for registrations, compliance, things
of that nature." Excerpts from the trial transcript follow, with the Q
indicating counsel's Question, and the A indicating Dr. Posner's Answer:

Q. So there are some concerns addressed here back in 1995 about testing up
to .8. And do you know what the nature of the concern was?

A. Yes. It was related to a side effect that occurred in the brain.

Q. Of what kind of animal?

A. It occurred in the brain of dogs.

Q. Okay. So there was a side effect that occurred in dogs, and then there
was a concern about whether you wanted to go forward and test at this higher
dose level in human beings, given what you had learned about the dogs,
right?

A. That's correct.

Q. Okay. Now, did you just say, well, let's forget about these concerns and
we'll go ahead and put .8 on the market anyway, or did you do some further
analysis that was not mentioned the other day?

A. Yes. The authors of this had -- they had two concerns. One concern was
the toxicity that they found in the brain of dogs. But the other was that
they had no way to identify this and who might be at risk before it
happened. So there was no way to detect that someone was at risk for this
side effect.

[skip some testimony on other topics]

Q. Do you remember in one kind of animal there had been some studies done
that there could be a particular kind of problem with one kind of animal?

A. Oh, yeah. Yes, from the -- that's correct, from the toxicology studies.

Q. Okay. And were you able to demonstrate to your own satisfaction, to
SmithKline's satisfaction, to the FDA's satisfaction, that that particular
problem that showed up with that kind of animal is not something that
happens in human beings?

A. Yes. We did it -- we did it by explaining the toxicology data. We also
explained it on the basis of kinetic data. That actually at the higher
levels of drug, what happens is a certain amount of drug is bound to
proteins in the body that circulate; and therefore, is not -- cannot cause
side effects. And actually, a much smaller proportion of the drug is free.
And that what you corrected for that, you actually found out that the
margins of safety were in fact greater than you would predict just from the
animal data.

Q. And as you move forward then and got approval and sold Baycol from 1997
through 2001, did that problem that had shown up with that one kind of
animal ever become a problem with human beings?

A. It was actually shown with other statins as well. It wasn't unique to
cerivastatin. It was a problem -- it was identified early on with lovastatin
and some of the others. In fact, for none of the statins did it ever predict
for any clinical problem or toxicity.

Q. So these animals would have that same problem regardless of which
statin -- or at least with other statins?

A. Certainly with lovastatin it was true.

Q. But when it came time to human beings, that just wasn't something that
happened to human beings?

A. And I think today no one pays much attention to it.

To my physician,

I believe that my symptoms may be due to the adverse effects associated with

cholesterol-lowering statin drugs. I need your help to understand the cause
of my

symptoms, treatment options, and the prognosis for my recovery.

Please review the references below, published medical studies that show
similar problems

associated with statin drugs. These are made available via the National
Institutes of

Health (NIH, http://www.ncbi.nlm.nih.gov/Entrez/) library of biomedical
journal

citations and other major repositories of medical research.

Also, I am respectfully requesting that you file an adverse effects report
with the FDA

(http://www.fda.gov/medwatch/how.htm), and that you please send a copy of
the report

to the to the NIH-funded Statin Study, attention: Dr. Beatrice Golomb,
Principal

Investigator.

Statin Study website: http://medicine.ucsd.edu/statin/

Statin Study contact info: http://medicine.ucsd.edu/statin/contactinfo.html

UCSD STATIN STUDY E-MAIL ADDRESS: statinstudy@ucsd.edu

MAILING ADDRESS: UCSD Statin Study 9500 Gilman Dr. La Jolla, CA 92093-0995

PHONE NUMBER: (858) 558-4950

Thank you

MEMORY LOSS & STATINS, AMNESIA & STATINS
Karen - 18 Feb 2006 14:28 GMT
We requested my MIL to be taken off of Lipitor during one of our periodic
audits of her pharmacy bills.  Her current doc told us that he left patients
on it unless otherwise requested because many families felt like it was a
denial of care to not provide all possible health care to their LO.  After
asking the caregivers, I found out that quite a few residents are on it.  To
what end, I can't imagine.  A heart attack seems kind compared to the
ravages I see.

Karen

> I think its unlikely that would happen, given that statins are generally
> prescribed for long term use, not much point staving off a heart attack in
> say 10-15 years time for someone whose life expectancy is 5-10 years
Sharon Hope - 18 Feb 2006 20:44 GMT
Karen,

That was a wise move.  Your MIL is lucky to have you watching out for her.
Did you notice if there were any difference in confusion?  (It can take
years for Lipitor cognitive damage to improve).

Also, do not fall into the marketing myth that the only choices in life are
Lipitor or death by heart attack.  People managed to survive before Lipitor.
The relative risk difference in survival that is provided by statins vs no
statins is very low.  Further, there is absolutely no evidence that statins
are effective for women or seniors.  In fact, the studies show that, in
women and elderly, the risk of serious adverse effects from statins is
higher than the "risk" of any benefit.

That is, in fact, the basis of a current class action lawsuit against statin
makers on behalf of women and the elderly.

See:
Plaintiffs Allege Promotional Scheme to Boost Sales of World's Best-Selling
Drug by Misleading Women and Seniors About Link Between the Drug and Heart
Disease

http://www.consumersunion.org/campaigns/prescriptionforchange/003006indiv.html

Class action lawsuit filed against Pfizer, Inc.
http://www.spacedoc.net/law/lipitor_litigation.htm

> We requested my MIL to be taken off of Lipitor during one of our periodic
> audits of her pharmacy bills.  Her current doc told us that he left
[quoted text clipped - 9 lines]
>> prescribed for long term use, not much point staving off a heart attack
>> in say 10-15 years time for someone whose life expectancy is 5-10 years
Karen - 19 Feb 2006 18:59 GMT
In the case of my MIL, there was no difference in confusion and the brain
scans had already shown a definite ALZ pattern of brain shrinkage.  It just
struck me as futile.

But doctors will perscribe preventative medications for their ALZ patients.
Early in the process of having to take charge of my MIL's affairs, we were
forced into getting her through a colonostomy.  Not because she had symptoms
calling for it but because she was over 50 and had never done one.  The
doc's words at that time were "She has Alzheimer's but you don't want her to
die of colon cancer."  I can't say how glad I was when circumstances changed
to the point that we could ditch that doc and get one that had a grip on
reality.

On the other hand, when my hubby's cholesterol was out of control (385) his
cardio tried to perscribe Lipitor.  When we expressed concern over side
effects, he said to try taking Benecol, 1 Tbsp with each meal.  It brought
his cholesterol down to under 200 in less than 3 months with no side effects
(then they told him to lower the amount to 1 tsp/meal).  I don't know why
more docs don't try it first.  Docs seem to think statins, reflux drugs and
Tylenol have no side effects and hand them out without trying other things
first.  I have reason to distrust all three.

Karen

> Karen,
>
[quoted text clipped - 22 lines]
> Class action lawsuit filed against Pfizer, Inc.
> http://www.spacedoc.net/law/lipitor_litigation.htm
Gwen Love - 19 Feb 2006 20:17 GMT
But there are also side effects of Benecol.
Gwen

> In the case of my MIL, there was no difference in confusion and the brain
> scans had already shown a definite ALZ pattern of brain shrinkage.  It
[quoted text clipped - 46 lines]
>> Class action lawsuit filed against Pfizer, Inc.
>> http://www.spacedoc.net/law/lipitor_litigation.htm
Karen - 20 Feb 2006 05:00 GMT
The only side effect my family has noticed in 3 years has been that it still
has calories (sigh!) which I have to remind Hubby about periodically.  What
side effects have you heard of?

Karen

--------------------
Their website lists none.
http://www.benecol.com/contactus/index.jhtml?id=benecol/contactus/faq_main.inc#S
ideEffects


Are there any potential side effects from consuming Plant Stanol Esters?
No, Plant Stanol Esters have an excellent safety profile which is
demonstrated by over 25 published clinical studies. Millions of individuals
have consumed BENECOL® Spread since its launch in Finland in 1995.
Furthermore, plant stanols are virtually unabsorbed by the body and are
excreted.
--------------------

> But there are also side effects of Benecol.
> Gwen
[quoted text clipped - 49 lines]
>>> Class action lawsuit filed against Pfizer, Inc.
>>> http://www.spacedoc.net/law/lipitor_litigation.htm
meg - 19 Feb 2006 15:50 GMT
> We requested my MIL to be taken off of Lipitor during one of our periodic
> audits of her pharmacy bills.  Her current doc told us that he left patients
[quoted text clipped - 5 lines]
>
> Karen

We requested that my mother be taken off of Lipitor because of the
sheer volume of pills she is taking.  Her doctor was a bit reluctant
because he implied it may help prevent stroke in addition to heart
attack.  He said a stroke and alz. is really bad.  We took her off
anyway because we weren't convinced.

It's a dilemma of sorts, my mother is on all sorts of medications to
prolong her life, so she can be ravaged by alz..  If I were in her
position, I don't know what I would chose.  Her will to live is strong,
though her quality of life is dimminishing rapidly.
Sharon Hope - 18 Feb 2006 20:36 GMT
>> Then, again, there is the too horrific to even contemplate possibility of
>> an ignorant doctor prescribing statins for an Alzheimer's patient, and
[quoted text clipped - 6 lines]
> prescribed for long term use, not much point staving off a heart attack in
> say 10-15 years time for someone whose life expectancy is 5-10 years

1) People should go by what has been proven in peer-reviewed published
medical journal studies, vs on what you may think you believe on a
particular day.

2) "Unlikely" does not mean it does not happen.  Statins caused memory loss,
dementia, confusion, cognitive damage, amnesia and aphasia in my husband.
Fact.  Many others have also taken statins and suffered similar disabling
side effects.

Do all statin users get the same side effects?  Obviously not.  Do many
suffer such statin adverse effects, even those whose doctors do not
recognize the problems as related?  Absolutely!

Dr. Muldoon's multiple studies, published in peer-reviewed medical journals,
show that after only 6 months a measurable difference in cognitive ability
can be measured between the placebo groups and the statin groups.
MEASURABLE impact to cognitive ability on statins after only 6 months.
These studies were conducted with different statins, and with different
doses of the same statin, and always the placebo group learned normally over
the 6 months time, and the statin group either failed to learn at all, or
learned at a much slower rate - MEASURABLE impact to cognitive ability on
statins after only 6 months.

Repeatable, measurable cognitive damage.  Note, too, that Dr. Muldoon's
studies halted after only 6 months, despite statins being prescribed for a
lifetime, so the measurable damage did not progress.  This in contrast to
doctors who continue to prescribe statins - known to cause cognitive damage
and memory loss - even after a patient develops cognitive damage and memory
loss.  AND the doctors commonly fail to investigate to find out specifically
if the statin is the cause of the memory loss.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstra
ct&list_uids=15589485&query_hl=4&itool=pubmed_DocSum

Am J Med. 2004 Dec 1;117(11):823-9.
Randomized trial of the effects of simvastatin on cognitive functioning in
hypercholesterolemic adults.

Muldoon MF, Ryan CM, Sereika SM, Flory JD, Manuck SB.

Center for Clinical Pharmacology, University of Pittsburgh, Pennsylvania
15260, USA. mfm10@pitt.edu

PURPOSE: In our initial study of the potential effects of
cholesterol-lowering interventions on cognitive functioning, treatment with
lovastatin as compared with placebo caused performance decrements on several
neuropsychological tests, whereas scores on other tests were unaffected. The
current study was designed to confirm and extend those findings. METHODS:
The study comprised 308 hypercholesterolemic adults between 35 and 70 years
of age. Employing a randomized double-blind design, we assigned participants
to daily treatment with placebo, 10 mg of simvastatin, or 40 mg of
simvastatin for 6 months. A neuropsychological test battery was administered
to assess cognitive functioning at baseline and at the end of the treatment
period. RESULTS: A total of 283 subjects completed the study: 94 subjects on
placebo, 96 taking 10 mg of simvastatin, and 93 taking 40 mg of simvastatin.
Compared with placebo, decremental effects of simvastatin treatment were
found on tests previously observed to be sensitive to statins (P = 0.008;
difference in summary z scores = 0.18; 95% confidence interval [CI]: 0.07 to
0.29) and on tests not previously administered (P = 0.04; difference in
summary z scores = 0.17; 95% CI: 0.05 to 0.29), but not on tests previously
observed to be insensitive to statins (P = 0.84; difference in summary z
scores = 0.02; 95% CI: -0.07 to 0.10). For the three tests specifically
affected by simvastatin, effects on cognitive performance were small,
manifest only as failure to improve during the 6 months of treatment
(compared with placebo), and were confounded by baseline differences on one
test. CONCLUSION: This study provides partial support for minor decrements
in cognitive functioning with statins. Whether such effects have any
long-term sequelae or occur with other cholesterol-lowering interventions is
not known.

Publication Types:
 a.. Clinical Trial
 b.. Randomized Controlled Trial

PMID: 15589485 [PubMed - indexed for MEDLINE]

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstra
ct&list_uids=10806282&query_hl=4&itool=pubmed_docsum

Am J Med. 2000 May;108(7):538-46.

Effects of lovastatin on cognitive function and psychological well-being.

Muldoon MF, Barger SD, Ryan CM, Flory JD, Lehoczky JP, Matthews KA, Manuck
SB.

Center for Clinical Pharmacology (MFM), University of Pittsburgh School of
Medicine, Pittsburgh, Pennsylvania, USA.

PURPOSE: Animal research and cross-sectional studies suggest that serum
lipid concentrations may influence cognitive function, mood, and behavior,
but few clinical trials have studied these effects. SUBJECTS AND METHODS: In
this double-blind investigation, 209 generally healthy adults with a serum
low-density-lipoprotein (LDL) cholesterol level of 160 mg/dL or higher were
randomly assigned to 6-month treatment with lovastatin (20 mg) or placebo.
Assessments of neuropsychological performance, depression, hostility, and
quality of life were conducted at baseline and at the end of the treatment
period. Summary effect sizes were estimated as z scores on a standard
deviation (SD) scale.RESULTS: Placebo-treated subjects improved between
baseline and posttreatment periods on neuropsychological tests in all five
performance domains, consistent with the effects of practice on test
performance (all P <0.04), whereas those treated with lovastatin improved
only on tests of memory recall (P = 0.03). Comparisons of the changes in
performance between placebo- and lovastatin-treated subjects revealed small,
but statistically significant, differences for tests of attention (z score =
0.18; 95% confidence interval (CI), 0.06 to 0.31; P = 0.005) and psychomotor
speed (z score = 0.17; 95% CI, 0.05 to 0.28; P = 0. 004) that were
consistent with greater improvement in the placebo group. Psychological
well-being, as measured several ways, was not affected by
lovastatin.CONCLUSION: Treatment of hypercholesterolemia with lovastatin did
not cause psychological distress or substantially alter cognitive function.
Treatment did result in small performance decrements on neuropsychological
tests of attention and psychomotor speed, the clinical importance of which
is uncertain.

Publication Types:
 a.. Clinical Trial
 b.. Randomized Controlled Trial

PMID: 10806282 [PubMed - indexed for MEDLINE]

> Tumbleweed
>
> email replies not necessary but to contact use;
> tumbleweednews at hotmail dot com
Tumbleweed - 19 Feb 2006 09:16 GMT
>>> Then, again, there is the too horrific to even contemplate possibility
>>> of an ignorant doctor prescribing statins for an Alzheimer's patient,
[quoted text clipped - 15 lines]
> husband. Fact.  Many others have also taken statins and suffered similar
> disabling side effects.

What I meant by 'unlikely', which I thought was clear but I'll try again to
be clear, is that for someone suffering with Az, that a doctor would then,
*after* that diagnosis, go on to prescribe statins for the first time, given
that statins are, by and large, as I understand it, a very long term
treatment.

> Do all statin users get the same side effects?  Obviously not.  Do many
> suffer such statin adverse effects, even those whose doctors do not
> recognize the problems as related?  Absolutely!

OK, so now you are saying that not everyone has side effects?

> Dr. Muldoon's multiple studies, published in peer-reviewed medical
> journals, show that after only 6 months a measurable difference in
[quoted text clipped - 5 lines]
> failed to learn at all, or learned at a much slower rate - MEASURABLE
> impact to cognitive ability on statins after only 6 months.

Or as the study itself says (which was for one particular statin only);

CONCLUSION: This study provides **partial** support for minor decrements in
cognitive function.

One study of course, does not a case make, you can find a study to support
whatever your POV is on pretty much any opinion.
FWIW there was a very large scale study in scandanavia recently which
'proved' the opposite, this was, IIRC, hundreds of thousand sof patients
compared to a fe hundred.

If course, side effects do happen, and if a drug has millions of people
taking it, then even low frequency side effects could have thousands of
people affected, which owuld potentially make for huge numbers posting on
web sites etc. Whether even low-percentage side effects make the drug worth
taking for the masses, depends on many things, including the litigious
nature of the society in which its taken.

Signature

Tumbleweed

email replies not necessary but to contact use;
tumbleweednews at hotmail dot com

Sharon Hope - 19 Feb 2006 18:37 GMT
>>>> Then, again, there is the too horrific to even contemplate possibility
>>>> of an ignorant doctor prescribing statins for an Alzheimer's patient,
[quoted text clipped - 42 lines]
> CONCLUSION: This study provides **partial** support for minor decrements
> in cognitive function.

That "one particular statin only" is why Dr. Muldoon did another test on
another statin at two different dosages, against a placebo group - the "gold
standard" of studies, and he found the same results.  Measurable cognitive
damage and memory loss after only 6 months in a drug that is prescribed for
a lifetime.

> One study of course, does not a case make, you can find a study to support
> whatever your POV is on pretty much any opinion.
[quoted text clipped - 6 lines]
> people affected, which owuld potentially make for huge numbers posting on
> web sites etc.

The problem is that there is NO TREATMENT for those thousands who have been
disabled by statins.

Given these are disabling adverse effects, and that they should be
PREVENTABLE if doctors are actively watching for these symptoms and ready to
intervene as soon as they appear, that would be responsible.

That is not the case in statins.

Historically, the marketing spin shows up every time a particular problem
gets some visibility.

For example, as soon as it became well established (but not all that
generally well-known) that statins CAUSE memory loss, the journals were
flooded by articles about industry-funded study starts having misleading
titles such as "Can Statins prevent Alzhiemers?"

The studies that have completed all FAILED to show any prevention of
Alzheimers, and none of these studies even discussed a method to be used to
differentiate between early Alzheimer's and statin-induced memory loss, yet
all the general public and the overworked docs remember is those empty
'marketing spin' headlines.

I cannot tell you how many patients have raised the concern of statin memory
loss to their physicians, only to be told (completely INACCURATELY) that
statins are used to treat Alz.  The doctor blows off the patient, and the
statin memory loss continues.

In our case, my husband's short-term memory was tested at below the 1
percentile before another doctor intervened.  He could not remember long
enough to process a 7 word sentence.  All due to 10mg/day of Lipitor over 4
years treatment.

There is no way that making people aware of these side effects should in any
way diminish the availability of statins for people who can tolerate them.
It is unconscionable to deny the side effects should be watched for to
intervene and prevent disabling damage.  That unconscionable situation
exists at this time.

>Whether even low-percentage side effects make the drug worth taking for the
>masses, depends on many things, including the litigious nature of the
>society in which its taken.
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2010 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.